Etanercept and urticaria in patients with juvenile idiopathic arthritis

Clinical and Experimental Rheumatology

Volumn 18, Issue 4, 2000, Pages 533-534

  Skytta, E ^a   Pohjankoski, H ^a   Savolainen, A ^a  

^a RHEUMATISM FOUNDATION HOSPITAL   (Finland)

Author keywords

Etanercept; Juvenile idiopathic arthriiis; Side effects; Urticaria

Indexed keywords

ETANERCEPT;

ARTHRITIS; ARTICLE; CASE REPORT; FEMALE; HUMAN; INJECTION SITE; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURIGO; RASH; UPPER RESPIRATORY TRACT INFECTION; URTICARIA;

ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; CHILD, PRESCHOOL; ELBOW; FEMALE; HUMANS; IMMUNOGLOBULIN G; RECEPTORS, TUMOR NECROSIS FACTOR; URTICARIA;

EID: 0033856364     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Safety and efficacy of tumor necrosis factor receptor P75 protein (TNRF:Fc, Enbrel®) in polyarticular course juvenile rheumatoid arthritis
2. Etanercept. A review of its use in rheumatoid arthritis
3. Safety and efficacy of Enbrel® D, (Etanercept) in the extended treatment of poly-articular course JRA